taurine has been researched along with Kidney Diseases in 33 studies
Kidney Diseases: Pathological processes of the KIDNEY or its component tissues.
| Excerpt | Relevance | Reference |
|---|---|---|
| "The antioxidative effects of melatonin (Mel), 5-hydroxytryptophan (5-HTP) and taurine (TAU) on hyperglycemia-induced oxidative stress was investigated in primary cultures of kidney-cortex tubule cells grown in metabolically and hormonally defined medium." | 7.74 | Melatonin is more effective than taurine and 5-hydroxytryptophan against hyperglycemia-induced kidney-cortex tubules injury. ( Bryla, J; Derlacz, RA; Drozak, J; Piekutowska, A; Sliwinska, M; Winiarska, K, 2007) |
| "Taurine is an endogenous antioxidant and a membrane-stabilizing, intracellular, free beta-amino acid." | 5.34 | The effect of taurine on renal ischemia/reperfusion injury. ( Demirogullari, B; Guz, G; Karasu, C; Lortlar, N; Nurlu, N; Omeroglu, S; Oz, E; Sert, S; Ulusu, NN, 2007) |
| " Molecular studies have shown that long noncoding RNAs (lncRNAs) and microRNAs (miRNAs) participate in renal fibrosis, while the roles of lncRNA taurine upregulated gene 1 (TUG1) and miR-140-3p in hyperuricemia-induced renal fibrosis remain less investigated." | 4.12 | lncRNA TUG1 regulates hyperuricemia-induced renal fibrosis in a rat model. ( Hu, L; Ma, C; Wei, J; Zhang, H; Zhang, Y, 2022) |
| " The present study assessed the ability of taurine (TAU) to alleviate or prevent AMK-induced nephrotoxicity if co-administrated with AMK focusing on inflammation, apoptosis, and fibrosis." | 4.02 | The nephroprotective properties of taurine-amikacin treatment in rats are mediated through HSP25 and TLR-4 regulation. ( Azmy, A; El-Amir, A; Madbouly, N; Salama, A, 2021) |
| "In fawn-hooded hypertensive (FHH) rats, a model of hypertension, impaired preglomerular resistance, hyperfiltration, and progressive renal injury, we recently observed that supporting perinatal nitric oxide (NO) availability with the NO donor molsidomine persistently reduced blood pressure (BP) and ameliorated renal injury in male and female offspring." | 3.76 | Perinatal micronutrient supplements ameliorate hypertension and proteinuria in adult fawn-hooded hypertensive rats. ( Braam, B; Goldschmeding, R; Joles, JA; Koeners, MP; van der Giezen, DM, 2010) |
| "The antioxidative effects of melatonin (Mel), 5-hydroxytryptophan (5-HTP) and taurine (TAU) on hyperglycemia-induced oxidative stress was investigated in primary cultures of kidney-cortex tubule cells grown in metabolically and hormonally defined medium." | 3.74 | Melatonin is more effective than taurine and 5-hydroxytryptophan against hyperglycemia-induced kidney-cortex tubules injury. ( Bryla, J; Derlacz, RA; Drozak, J; Piekutowska, A; Sliwinska, M; Winiarska, K, 2007) |
| "Hemorrhage was present in the kidneys of all groups." | 1.48 | Energy drink and alcohol combination leads to kidney and liver alterations in rats. ( Altknecht, L; Arbo, MD; Cestonaro, LV; Costa-Valle, MT; Cunha, CD; Dallegrave, E; Fão, N; Garcia, SC; Göethel, G; Leal, MB; Tonieto, BD, 2018) |
| "Treatment with taurine, prior to administration of KBrO3, resulted in significant attenuation in all these parameters but the administration of taurine alone had no effect." | 1.39 | Taurine ameliorates potassium bromate-induced kidney damage in rats. ( Ahmad, MK; Khan, AA; Mahmood, R, 2013) |
| "Treatment with taurine prior to arsenic administration effectively ameliorated As-induced oxidative renal dysfunctions and apoptotic cell death." | 1.35 | Prophylactic role of taurine on arsenic mediated oxidative renal dysfunction via MAPKs/ NF-kappaB and mitochondria dependent pathways. ( Manna, P; Roy, A; Sil, PC, 2009) |
| "Treatment with taurine (at a dose of 100 mg/kg body weight for 5 days) before cadmium intoxication prevented the toxin-induced oxidative impairments in renal tissues." | 1.35 | Taurine plays a beneficial role against cadmium-induced oxidative renal dysfunction. ( Manna, P; Sil, PC; Sinha, M, 2009) |
| "Taurine is an endogenous antioxidant and a membrane-stabilizing, intracellular, free beta-amino acid." | 1.34 | The effect of taurine on renal ischemia/reperfusion injury. ( Demirogullari, B; Guz, G; Karasu, C; Lortlar, N; Nurlu, N; Omeroglu, S; Oz, E; Sert, S; Ulusu, NN, 2007) |
| "Tamoxifen (TAM) is an anti-neoplastic drug used for the treatment of breast cancer." | 1.34 | Nephrotoxicity and its prevention by taurine in tamoxifen induced oxidative stress in mice. ( Dev Banerjee, B; Parvez, S; Raisuddin, S; Rehman, H; Siemen, D; Tabassum, H, 2007) |
| "Normal rats, those with streptozocin diabetes, puromycin aminonucleoside nephropathy, bilateral ureteral ligation, and 5/6 nephrectomy were studied." | 1.29 | Immunohistochemical localization of taurine in rat renal tissue: studies in experimental disease states. ( Lu, P; Sturman, JA; Trachtman, H, 1993) |
| "Taurine-treated nephrotic rats had a reduction in albuminuria, as assessed by the urinary albumin-to-creatinine ratio (26 +/- 4 vs." | 1.28 | Taurine attenuates renal disease in chronic puromycin aminonucleoside nephropathy. ( Del Pizzo, R; Futterweit, S; Levine, D; Rao, PS; Sturman, JA; Trachtman, H; Valderrama, E, 1992) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (6.06) | 18.7374 |
| 1990's | 3 (9.09) | 18.2507 |
| 2000's | 9 (27.27) | 29.6817 |
| 2010's | 17 (51.52) | 24.3611 |
| 2020's | 2 (6.06) | 2.80 |
| Authors | Studies |
|---|---|
| Zhang, Y | 1 |
| Zhang, H | 1 |
| Hu, L | 1 |
| Wei, J | 1 |
| Ma, C | 1 |
| Patel, SN | 1 |
| Lau-Cam, CA | 1 |
| Ma, N | 1 |
| Kato, T | 1 |
| Isogai, T | 1 |
| Gu, Y | 1 |
| Yamashita, T | 1 |
| Madbouly, N | 1 |
| Azmy, A | 1 |
| Salama, A | 1 |
| El-Amir, A | 1 |
| Abdel-Wahab, WM | 1 |
| Moussa, FI | 1 |
| Saad, NA | 1 |
| Costa-Valle, MT | 1 |
| Tonieto, BD | 1 |
| Altknecht, L | 1 |
| Cunha, CD | 1 |
| Fão, N | 1 |
| Cestonaro, LV | 1 |
| Göethel, G | 1 |
| Garcia, SC | 1 |
| Leal, MB | 1 |
| Dallegrave, E | 1 |
| Arbo, MD | 1 |
| Heidari, R | 1 |
| Behnamrad, S | 1 |
| Khodami, Z | 1 |
| Ommati, MM | 1 |
| Azarpira, N | 1 |
| Vazin, A | 1 |
| Ahmad, MK | 1 |
| Khan, AA | 1 |
| Mahmood, R | 1 |
| Velloso, MS | 1 |
| Otoni, A | 1 |
| de Paula Sabino, A | 1 |
| de Castro, WV | 1 |
| Pinto, SW | 1 |
| Marinho, MA | 1 |
| Rios, DR | 1 |
| Zou, ZJ | 1 |
| Xie, YY | 1 |
| Gong, MJ | 1 |
| Han, B | 1 |
| Wang, SM | 1 |
| Liang, SW | 1 |
| Branco, RC | 1 |
| Batista, TM | 1 |
| Camargo, RL | 1 |
| Borck, PC | 1 |
| Ribeiro, RA | 1 |
| Zoppi, CC | 1 |
| Lollo, PC | 1 |
| Morato, PN | 1 |
| Boschero, AC | 1 |
| Carneiro, EM | 1 |
| Basalai, ON | 1 |
| Mikhalchuk, ECh | 1 |
| Zimatkin, SM | 1 |
| Bushma, MI | 1 |
| Adedara, IA | 1 |
| Ojuade, TJD | 1 |
| Olabiyi, BF | 1 |
| Idris, UF | 1 |
| Onibiyo, EM | 1 |
| Ajeigbe, OF | 1 |
| Farombi, EO | 1 |
| Ozden, S | 1 |
| Catalgol, B | 1 |
| Gezginci-Oktayoglu, S | 1 |
| Arda-Pirincci, P | 1 |
| Bolkent, S | 1 |
| Alpertunga, B | 1 |
| Roy, A | 2 |
| Manna, P | 2 |
| Sil, PC | 3 |
| Koeners, MP | 1 |
| Braam, B | 1 |
| van der Giezen, DM | 1 |
| Goldschmeding, R | 1 |
| Joles, JA | 1 |
| O'Donnell, DH | 1 |
| Moloney, MA | 1 |
| Bouchier-Hayes, DJ | 1 |
| Lee, MJ | 1 |
| Mozaffari, MS | 1 |
| Abdelsayed, R | 1 |
| Patel, C | 1 |
| Wimborne, H | 1 |
| Liu, JY | 1 |
| Schaffer, SW | 1 |
| Chesney, RW | 2 |
| Han, X | 2 |
| Patters, AB | 1 |
| Das, J | 1 |
| Braumann, C | 1 |
| Stuhldreier, B | 1 |
| Bobrich, E | 1 |
| Menenakos, C | 1 |
| Rogalla, S | 1 |
| Jacobi, CA | 1 |
| Hagar, HH | 1 |
| El Etter, E | 1 |
| Arafa, M | 1 |
| Guz, G | 1 |
| Oz, E | 1 |
| Lortlar, N | 1 |
| Ulusu, NN | 1 |
| Nurlu, N | 1 |
| Demirogullari, B | 1 |
| Omeroglu, S | 1 |
| Sert, S | 1 |
| Karasu, C | 1 |
| Derlacz, RA | 1 |
| Sliwinska, M | 1 |
| Piekutowska, A | 1 |
| Winiarska, K | 1 |
| Drozak, J | 1 |
| Bryla, J | 1 |
| Tabassum, H | 1 |
| Parvez, S | 1 |
| Rehman, H | 1 |
| Dev Banerjee, B | 1 |
| Siemen, D | 1 |
| Raisuddin, S | 1 |
| Sinha, M | 1 |
| Trachtman, H | 3 |
| Sturman, JA | 3 |
| Lu, P | 1 |
| Cruz, CI | 1 |
| Ruiz-Torres, P | 1 |
| del Moral, RG | 1 |
| Rodríguez-Puyol, M | 1 |
| Rodríguez-Puyol, D | 1 |
| Del Pizzo, R | 1 |
| Futterweit, S | 1 |
| Levine, D | 1 |
| Rao, PS | 1 |
| Valderrama, E | 1 |
| Lawson, AM | 1 |
| Madigan, MJ | 1 |
| Shortland, D | 1 |
| Clayton, PT | 1 |
| Dunn, HG | 1 |
| Perry, TL | 1 |
| Dolman, CL | 1 |
6 reviews available for taurine and Kidney Diseases
| Article | Year |
|---|---|
The Potential Effects of Taurine in Mitigation of Radiation Nephropathy.
Topics: Humans; Kidney; Kidney Diseases; Membrane Glycoproteins; Membrane Transport Proteins; Oxidative Stre | 2019 |
Peritoneal dialysis and inflammation.
Topics: Dialysis Solutions; Glucans; Glucose; Humans; Hydrogen-Ion Concentration; Icodextrin; Inflammation; | 2014 |
Taurine and the renal system.
Topics: Animals; Apoptosis; Cell Cycle; Humans; Ions; Kidney; Kidney Diseases; Kidney Glomerulus; Osmolar Co | 2010 |
The role of taurine in renal disorders.
Topics: Animals; Humans; Kidney Diseases; Kidney Function Tests; Taurine | 2012 |
Mechanism of the protective action of taurine in toxin and drug induced organ pathophysiology and diabetic complications: a review.
Topics: Animals; Antioxidants; Arsenic; Blood Pressure; Cadmium; Calcium; Chemical and Drug Induced Liver In | 2012 |
Taurine and experimental kidney disease.
Topics: Animals; Cell Division; Cell Line; Diabetic Nephropathies; Disease Models, Animal; Kidney Diseases; | 1994 |
27 other studies available for taurine and Kidney Diseases
| Article | Year |
|---|---|
lncRNA TUG1 regulates hyperuricemia-induced renal fibrosis in a rat model.
Topics: Animals; Cell Proliferation; Fibrosis; Hyperuricemia; Kidney Diseases; MicroRNAs; Rats; RNA, Long No | 2022 |
Modification by Ethanol and Taurine, Singly and in Combination, of Changes in Indices of Renal Dysfunction Caused by Diabetes in Rats.
Topics: Animals; Blood Glucose; Diabetes Mellitus, Experimental; Ethanol; Kidney Diseases; Male; Rats; Rats, | 2019 |
The nephroprotective properties of taurine-amikacin treatment in rats are mediated through HSP25 and TLR-4 regulation.
Topics: Amikacin; Animals; Anti-Bacterial Agents; Apoptosis; Blood Urea Nitrogen; Creatinine; Dose-Response | 2021 |
Synergistic protective effect of
Topics: Acetylcysteine; Animals; Antineoplastic Agents; Cisplatin; Kidney Diseases; Kidney Function Tests; M | 2017 |
Energy drink and alcohol combination leads to kidney and liver alterations in rats.
Topics: Alcoholic Beverages; Animals; Behavior, Animal; Caffeine; Central Nervous System Stimulants; Chemica | 2018 |
The nephroprotective properties of taurine in colistin-treated mice is mediated through the regulation of mitochondrial function and mitigation of oxidative stress.
Topics: Animals; Anti-Bacterial Agents; Antioxidants; Colistin; Dose-Response Relationship, Drug; Kidney Dis | 2019 |
Taurine ameliorates potassium bromate-induced kidney damage in rats.
Topics: Animals; Bromates; DNA Damage; Humans; Kidney; Kidney Diseases; Lipid Peroxidation; Male; Oxidative | 2013 |
[Urine metabonomic study of intervention effects of Morinda officinalis how. on 'kidney-yang deficiency syndrome'].
Topics: Alanine; Animals; Betaine; Biomarkers; Citric Acid; Drugs, Chinese Herbal; Hydrocortisone; Ketogluta | 2013 |
Long-term taurine supplementation leads to enhanced hepatic steatosis, renal dysfunction and hyperglycemia in mice fed on a high-fat diet.
Topics: Adiposity; Animals; Blood Glucose; Body Weight; Diet, High-Fat; Fatty Liver; Hyperglycemia; Kidney D | 2015 |
[COMBINATION OF TAURINE WITH ZINC DIASPARTATE FOR CORRECTION OF METABOLISM DISTURBANSES IN NEPHRONS AND RENAL FUNCTION IN RATS WITH CONTRAST-INDUCED NEPHROPATHY].
Topics: Animals; Aspartic Acid; Kidney Diseases; Male; Nephrons; Rats; Taurine; Zinc | 2015 |
Taurine Ameliorates Renal Oxidative Damage and Thyroid Dysfunction in Rats Chronically Exposed to Fluoride.
Topics: Animals; Fluorides; Kidney; Kidney Diseases; Male; Oxidative Stress; Rats; Rats, Wistar; Taurine; Th | 2017 |
Methiocarb-induced oxidative damage following subacute exposure and the protective effects of vitamin E and taurine in rats.
Topics: Animals; Antioxidants; Chemical and Drug Induced Liver Injury; Glutathione; Insecticides; Kidney Dis | 2009 |
Prophylactic role of taurine on arsenic mediated oxidative renal dysfunction via MAPKs/ NF-kappaB and mitochondria dependent pathways.
Topics: Animals; Arsenites; Cell Death; Kidney; Kidney Diseases; Male; MAP Kinase Signaling System; Mitochon | 2009 |
Perinatal micronutrient supplements ameliorate hypertension and proteinuria in adult fawn-hooded hypertensive rats.
Topics: Animals; Arginine; Ascorbic Acid; Blood Pressure; Dietary Supplements; Female; Hypertension; Kidney | 2010 |
Contrast-induced nephrotoxicity: possible synergistic effect of stress hyperglycemia.
Topics: Acetylcysteine; Analysis of Variance; Animals; Apoptosis; Contrast Media; Dogs; Hyperglycemia; Kidne | 2010 |
Differential effects of taurine treatment and taurine deficiency on the outcome of renal ischemia reperfusion injury.
Topics: Animals; Apoptosis; Aquaporin 2; Cell Proliferation; Kidney; Kidney Diseases; Kidney Function Tests; | 2010 |
High doses of taurolidine inhibit advanced intraperitoneal tumor growth in rats.
Topics: Adenocarcinoma; Animals; Antineoplastic Agents; Biopsy; Cell Division; Cell Line, Tumor; Chemical an | 2005 |
Taurine attenuates hypertension and renal dysfunction induced by cyclosporine A in rats.
Topics: Animals; Blood Pressure; Body Weight; Catalase; Cyclosporine; Glutathione; Glutathione Peroxidase; H | 2006 |
The effect of taurine on renal ischemia/reperfusion injury.
Topics: Animals; Antioxidants; Biomarkers; Kidney; Kidney Diseases; Male; Random Allocation; Rats; Rats, Wis | 2007 |
Melatonin is more effective than taurine and 5-hydroxytryptophan against hyperglycemia-induced kidney-cortex tubules injury.
Topics: 5-Hydroxytryptophan; Animals; Hyperglycemia; Kidney Cortex; Kidney Diseases; Kidney Tubules; Male; M | 2007 |
Nephrotoxicity and its prevention by taurine in tamoxifen induced oxidative stress in mice.
Topics: Administration, Oral; Animals; Antioxidants; Catalase; Cytochrome P-450 Enzyme System; Enzyme Activa | 2007 |
Taurine plays a beneficial role against cadmium-induced oxidative renal dysfunction.
Topics: Animals; Antioxidants; Ascorbic Acid; Cadmium Chloride; DNA Fragmentation; Kidney; Kidney Diseases; | 2009 |
Immunohistochemical localization of taurine in rat renal tissue: studies in experimental disease states.
Topics: Animals; Diabetes Mellitus, Experimental; Immunohistochemistry; Kidney Diseases; Kidney Glomerulus; | 1993 |
Age-related progressive renal fibrosis in rats and its prevention with ACE inhibitors and taurine.
Topics: Age Factors; Angiotensin-Converting Enzyme Inhibitors; Animals; Antioxidants; Captopril; Extracellul | 2000 |
Taurine attenuates renal disease in chronic puromycin aminonucleoside nephropathy.
Topics: Animals; Chronic Disease; Creatinine; Kidney; Kidney Diseases; Male; Proteinuria; Puromycin Aminonuc | 1992 |
Rapid diagnosis of Zellweger syndrome and infantile Refsum's disease by fast atom bombardment--mass spectrometry of urine bile salts.
Topics: Bile Acids and Salts; Brain Diseases; Chemical Fractionation; Cholic Acids; Female; Gas Chromatograp | 1986 |
Homocystinuria. A recently discovered cause of mental defect and cerebrovascular thrombosis.
Topics: Adolescent; Adult; Amino Acid Metabolism, Inborn Errors; Animals; Blood; Blood Coagulation Disorders | 1966 |